Benjamin J. Hindson - 22 May 2025 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
President and Chief Scientific Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Benjamin J. Hindson
Issuer symbol
TXG
Transactions as of
22 May 2025
Net transactions value
-$62,120
Form type
4
Filing time
27 May 2025, 17:07:25 UTC
Previous filing
19 Mar 2025
Next filing
26 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hindson Benjamin J. President and Chief Scientific Officer, Director 10X GENOMICS, INC., 6230 STONERIDGE MALL ROAD, PLEASANTON /s/ Eric S. Whitaker, as Attorney-in-Fact for Benjamin J. Hindson 27 May 2025 0001786391

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale $62,120 -7,485 -1.6% $8.30 448,374 22 May 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

President and Chief Scientific Officer